View Meeting Video
Friday, January 31, 2025
A CME/CNE-accreditted
patient & caregiver program
7:00 am - 4:00 pm EST
In-person or virtual
Law Auditorium | Jordan Medical Education Center
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
Overview
The purpose of this educational activity is to provide a review of new treatment options in neuro-oncology, including surgical techniques, and intraoperative imaging, along with, radiation and systemic therapies that have improved patient outcomes. Sessions will feature the latest advances in state-of-the-art care for practicing clinicians treating patients with brain tumors. Cutting-edge topics in precision medicine, including genetic, translational, and clinical research will also be featured. Activity format will provide significant opportunity for interaction with expert faculty and other attendees with the aim of implementing new standards of patient care. Participants will leave with up-to-date, practical information which will have immediate clinical application, as well as technical and scientific background on the current state, and where the latest scientific advances may take the field.
Who Should Attend
This symposium is designed for neurosurgeons, neurooncologists, neurologists, neuroradiologists, radiologists, medical oncologists, radiation oncologists, pathologists, primary care physicians, oncology nurses, and other healthcare professionals involved in the treatment of patients with brain tumors. Additionally, patients and their caregivers, family members, advocates and members of the public who may benefit from understanding current innovative approaches to brain tumor care are invited.
Learning Objectives
Upon completion of this course, participants should be able to:
- Evaluate the latest advancements in brain cancer diagnosis and treatment.
- Review the role of innovative technologies like LITT, molecular profiling, and neuroimaging in improving patient care.
- Analyze the current landscape of CAR T-cell therapy for brain tumors and its future potential.
- Explore emerging technologies and strategies for optimizing surgery and immunotherapy for gliomas.
- Assess the impact of the INDIGO trial on the treatment of IDH-mutant low-grade gliomas.
- Gain practical knowledge in medical and symptom management for patients with brain tumors.
- Evaluate the latest advancements in liquid biopsy, radiation therapy, and targeted treatments for brain tumors.
- Explore the potential of mRNA technology and intraoperative molecular imaging in improving outcomes for brain tumor patients.
For additional information please contact Gabrielle White.